Systemic Therapeutics Corp. is a Canadian pre-clinical stage, biotechnology company specialized in the development of new therapies focusing on the master regulator of lipid metabolism, sterol regulatory-element binding proteins (SREBP), based on first-in-class small molecule SREBP inhibitors. The company aims to provide new treatment options for metabolic conditions such as dyslipidemia, via reduction of circulating PCSK9, and Non-Alcoholic Fatty Liver Disease. Systemic is pioneering a new approach to the care of metabolic disorders.
Co-Founder, Executive Chairman and Chief Scientific Officer
Co-Founder and Vice President, Drug Discovery
Co-Founder and Chief Medical Officer
Co-Founder and Vice President, Business Development
Intellectual Property
Fundraising
Founders Fast Track is 6 week mentorship program that provides your startup with access to industry expertise, resources, networking opportunities, and skills to help you secure investment capital.
Applications are open until April 13, 2025.
Innovation Factory’s Synapse Competition is Ontario’s premier life science pitch competition, dedicated to fostering innovation in the life science sector.
March 26, 2025 | 4:00pm – 8:00pm EDT
